Isaac Sanchez-Rosado

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection.

Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: June 19, 2023

Partial restoration of gut-mucosal dysbiosis in late-treated HIV-infected subjects with CD4 T-cell recovery.

Partial restoration of gut-mucosal dysbiosis in late-treated HIV-infected subjects with CD4 T-cell recovery.

Journal: Clinical and translational medicine

Published: January 04, 2022

Gal3 Plays a Deleterious Role in a Mouse Model of Endotoxemia.

Gal3 Plays a Deleterious Role in a Mouse Model of Endotoxemia.

Journal: International journal of molecular sciences

Published: October 29, 2021

Immunological features beyond CD4/CD8 ratio values in older individuals.

Immunological features beyond CD4/CD8 ratio values in older individuals.

Journal: Aging

Published: January 28, 2021

Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects.

Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects.

Journal: Frontiers in immunology

Published: July 29, 2020

New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144.

New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144.

Journal: Scientific reports

Published: August 15, 2019

Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients.

Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients.

Journal: Clinical science (London, England : 1979)

Published: February 12, 2019

Effect of homeostatic T-cell proliferation in the vaccine responsiveness against influenza in elderly people.

Effect of homeostatic T-cell proliferation in the vaccine responsiveness against influenza in elderly people.

Journal: Immunity & ageing : I & A

Published: February 11, 2019

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.

Journal: Journal of translational medicine

Published: May 23, 2018

HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation.

HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation.

Journal: Frontiers in immunology

Published: May 09, 2018

Role of toll-like receptor 4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients.

Role of toll-like receptor 4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients.

Journal: AIDS (London, England)

Published: March 17, 2018

Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response.

Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response.

Journal: Antimicrobial agents and chemotherapy

Published: October 05, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026